1108 Clinical Trials for: HIV-1 Infection, Page 1 of Results

1
Completed
Short Course Antiretroviral Therapy for Early HIV-1 Infection
Condition(s): HIV-1 Infection
2
Not yet recruiting
Optimisation of Primary HIV1 Infection Treatment
Condition(s): HIV-1 Infections
3
Completed
Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
Condition(s): HIV Infections
4
Recruiting
Observational Study of Treated and Untreated Acute and Early HIV-1 Infection
Condition(s): HIV Infections
5
Completed
Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection
Condition(s): HIV Infection
6
Completed
A Phase II Study of Low-Dose Interleukin-2 by Subcutaneous Injection in Combination With Antiretroviral Therapy Versus Antiretroviral Therapy Alone in Patients With HIV-1 Infection and at Least 3 Months Stable Antiretroviral Therapy
Condition(s): HIV Infections
7
Recruiting
Examining Factors That May Influence Resistance to HIV-1 Infection
Condition(s): HIV Infections
8
Completed
Assessment of Attentional Functioning in Children With HIV-1 Infection
Condition(s): Attention Deficit Disorder With Hyperactivity; HIV Infections; Paralysis
9
Completed
A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection
Condition(s): HIV Infections; Leukoencephalopathy, Progressive Multifocal
10
Recruiting
Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study
Condition(s): HIV Infections
11
Completed
Phase I/II, Open-Label Trial of Three Monoclonal Antibodies
Condition(s): HIV Infections
12
Recruiting
A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.
Condition(s): HIV Infections
13
Completed
An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen
Condition(s): HIV Infections
14
Completed
Study of PRO 140 by Subcutaneous Administration in Adult Subjects With HIV -1 Infection
Condition(s): HIV -1 Infection; HIV Infections
15
Completed
Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
Condition(s): HIV Infections
16
Completed
Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
Condition(s): HIV Infections
17
Recruiting
Nelfinavir and M8 Drug-Level Monitoring in HIV-1 Infection
Condition(s): HIV Infections
18
Completed
A Pilot Study of the Effect of Minocycline on Cerebrospinal Fluid HIV-1 Infection
Condition(s): HIV Infection
19
Recruiting
Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
Condition(s): HIV Infections
20
Completed
HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
Condition(s): HIV-1 Infection

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

Page 1 of Clinical Trials for HIV-1 Infection, 1108 Total Matches

Clinical Trials Authorship and Review